This Million Shows Growing Confidence in 10x Genomics
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesA hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Fintech investing has moved fast. This article compares PayPal and SoFi, explains whether PayPal is truly yesterday's...
Bitcoin, XRP and Ethereum moved in narrow ranges on Feb. 24, 2026, as traders weigh macro data and liquidity conditio...
Federal prosecutors dismantle a sprawling fraud machine that used mass texting, scripted pitches, and fake crypto pla...
As money flows into SPY accelerate, four small-cap ETFs are quietly delivering outsized gains. This report breaks dow...
A $1.8 billion slush fund to reimburse Trump allies for legal costs sparks a GOP backlash. The move raises red flags ...
New 2026 guidance shows high earners with million+ 401(k)s can still build tax-free Roth assets through after-tax con...
Regulated banks can custody crypto and settle tokenized funds, but Basel's capital rules impose a punishing cost that...
AI funding is surging in 2026, signaling a new investment wave. Here's how an investor ahead next investment can posi...
A routine cash withdrawal becomes a clue in a larger investigation. Learn how a $560 ATM event helped uncover extensi...
US Treasuries are amplifying market selloffs, dragging Bitcoin lower as risk-off trades surge. Analysts say tradition...
A strong pharma dividend stock could be a powerful component of a retirement plan. Learn how to choose, invest, and c...